Video Event | The Role of Medical Innovation and Patents in Defeating the "Invisible Enemy"

May 2020

Past Event

Video Event | The Role of Medical Innovation and Patents in Defeating the "Invisible Enemy"

Past Event

Hudson Institute, Washington, D.C. Headquarters

May 22, 2020

May 2020

Past Event

1201 Pennsylvania Avenue, N.W., Suite 400
Washington, DC 20004

Speakers:

Adam Mossoff

Senior Fellow, Hudson Institute

Frederick Reinhart

Senior Advisor for Technology Transfer, University of Massachusetts Amherst

Melissa Brand

Assistant General Counsel and Director for Intellectual Property, Biotechnology Innovation Organization

Eric Victory

Vice President for Global Strategic Marketing, Aurinia Pharmaceuticals

**__Please be advised: This event will be premiering at 9:00 a.m. EDT, Friday, May 22. You may view this event on Hudson’s website at or after its premiere time on this event page.__**

COVID-19 has inflicted worldwide economic damage and killed hundreds of thousands of people. However, because of the innovative potential of the modern biopharmaceutical industry, it is unlikely to be a repeat of the Spanish Flu Pandemic of 1918, which killed tens of millions of people around the globe.

Companies like Gilead, Moderna, and many others are investing billions of dollars and thousands of labor hours to create new tests, treatments, and a vaccine to minimize, if not effectively eradicate, the coronavirus.

Join Hudson Institute for a discussion with top industry experts on the role of patents in funding innovative developments; why some policy-makers have proposed restricting or eliminating patent rights on COVID-19 related treatments or vaccines; and how empowering the private-sector is a likely winning strategy in the battle to defeat the "invisible enemy."

June 2026

Virtual Event | Hudson Institute

Authoritarian Persistence in Latin America: What Should the US Do?

Featured Speakers:

Elliot Abrams

Daniel Batlle

June 2026

Virtual Event | Hudson Institute

Authoritarian Persistence in Latin America: What Should the US Do?

Please join Adjunct Fellow Daniel Batlle for a conversation with Elliott Abrams, whose leadership on Latin America policy stretches from his service as assistant secretary of state for inter-American affairs under President Ronald Reagan to his role as special representative for Venezuela in the first Trump administration.

Featured Speakers:

Elliot Abrams

Daniel Batlle

Learn More

June 2026

In-Person Event | Hudson Institute

Spain’s Latin American Reckoning

Featured Speakers:

Julio Crespo MacLennan

Daniel Batlle

June 2026

In-Person Event | Hudson Institute

Spain’s Latin American Reckoning

Join Hudson as Adjunct Fellow Daniel Batlle sits down with Julio Crespo MacLennan, a historian and one of the leading scholars on Spain’s democratic transition and on Europe’s relationship with the wider world.

Featured Speakers:

Julio Crespo MacLennan

Daniel Batlle

Learn More

June 2026

In-Person Event | Hudson Institute

Growing the DIB: A Conversation with Deputy Assistant Secretary of War James Mismash

Featured Speakers:

Nadia Schadlow

James Mismash

June 2026

In-Person Event | Hudson Institute

Growing the DIB: A Conversation with Deputy Assistant Secretary of War James Mismash

Please join Hudson Institute for a fireside chat between Hudson Senior Fellow Nadia Schadlow and Deputy Assistant Secretary for Industrial Base Growth and Director of the Office of Small Business Programs James Mismash.

Featured Speakers:

Nadia Schadlow

James Mismash

Learn More

June 2026

In-Person Event | Hudson Institute

Winning the Innovation Competition

Featured Speakers:

Bryan Clark

Dan Patt

Emil Michael

June 2026

In-Person Event | Hudson Institute

Winning the Innovation Competition

Please join Hudson Institute Senior Fellows Bryan Clark and Dan Patt for a conversation with Under Secretary of War for Research and Engineering Emil Michael about the Department of War’s efforts to bring AI to the battlefield and implement an innovation strategy that makes the most of America’s commercial and government research sectors.